Phase Forward has announced that its InForm electronic data capture (EDC) solution has been utilized in more than 3,000 live or completed clinical trials to date with end users in 112 countries across the globe.
Reportedly, the announcement comes as the company last month unveiled a new generation of InForm, the InForm Global Trial Management (GTM) eClinical solution.
The company said that the InForm GTM addresses the paradigm shift in usability requirements resulting from the maturation of the EDC market whereby longer and more complex trials are managed by more sophisticated and knowledgeable EDC users who require more information.
The company said that InForm is a key part of Phase Forward’s suite of solutions offering customers of the world an integrated clinical research suite (ICRS) from study set-up, through analysis and submission.
Reportedly, the InForm solution, together with Phase Forward’s Clarix interactive response technology (IRT) for randomization and trial supply management; the recently acquired Waban Software platform for the management of all clinical data, analysis and reports; and the Empirica safety and pharmacovigilance product sets, offers customers an end-to-end eClinical solution for efficiently managing all their trials.
Bob Weiler, chairman and CEO of Phase Forward, said: We are proud of the leadership role we have played in pioneering the broad adoption of EDC technology to help bring essential treatments to market more quickly. We’re thrilled to have reached the 3,000 trials milestone with InForm, and we look forward to continuing to set new standards for eClinical solutions.
